Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients: A Randomized Controlled Trial

NCT07273812 is registered in ClinicalTrials.gov with Dena h. Al-Tameemi as lead sponsor.

NCT NCT07273812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07273812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients: A Randomized Controlled Trial
Lead sponsor
Dena h. Al-Tameemi
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2026
Completion date
November 6, 2026
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

accuracy of ai app, breast cancer, breast neoplasm, chemotherapy-related toxicities, medication adherence, quality of life in cancer patients, symptom management